id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-E-1091-0002,FDA,FDA-2021-E-1091,Patent Extension Application from Fish & Richardson P.C. (on behalf of Incyte Corporation),Other,Application,2021-10-12T04:00:00Z,2021,10,2021-10-12T04:00:00Z,,2021-10-12T14:56:45Z,,0,0,0900006484dc20b5
FDA-2021-E-1091-0001,FDA,FDA-2021-E-1091,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2021-10-12T04:00:00Z,2021,10,2021-10-12T04:00:00Z,,2021-10-12T14:56:37Z,,0,0,0900006484dc24f8
FDA-2021-E-1091-0003,FDA,FDA-2021-E-1091,Appendix A re Patent Extension Application from Fish & Richardson P.C. (on behalf of Incyte Corporation),Supporting & Related Material,Background Material,2021-10-12T04:00:00Z,2021,10,,,2021-10-12T14:56:53Z,,0,0,0900006484dc20b7